Information and interesting ideas

Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.

Tuesday, January 9, 2024

ACRO and Trancelerate release infographic on ICH E6(R3) Good Clinical Practice guideline vs R2

If you have or haven't looked at the ICH E6 revision 3 GCP guideline, this may be of interest to see how others perceive the differences from the current guideline.

 From the LinkedIn announcement:

TransCelerate is excited to announce the release of a new co-created resource! We have partnered with the Association of Clinical Research Organizations (ACRO) to release a new infographic that features the key changes to risk management in ICH E6 (R3) between Version 2 and 3.  

#goodclinicalpractice #acceleratinganswers #collaboration 

Learn more and check out the new infographic: https://lnkd.in/gGC-fJtR 

at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made

This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...